Ocugen, Inc. (OCGN)

NASDAQ: OCGN · Real-Time Price · USD

1.240

+0.060 (5.08%)

At close: Nov 28, 2025, 1:00 PM EST

1.230

-0.010 (-0.81%)

After-hours: Nov 28, 2025, 4:59 PM EST

Ocugen Employees

Ocugen had 95 employees as of December 31, 2024. The number of employees increased by 30 or 46.15% compared to the previous year.

Employees

95

Change (1Y)

30

Growth (1Y)

46.15%

Revenue / Employee

$56,526

Profits / Employee

-$673,895

Market Cap

387.28M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	95	30	46.15%
Dec 31, 2023	65	-19	-22.62%
Dec 31, 2022	84	28	50.00%
Dec 31, 2021	56	41	273.33%
Dec 31, 2020	15	-1	-6.25%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

OCGN News

9 days ago - Ocugen CEO to Present at NobleCon21—Noble Capital Markets' Twenty-First Annual Emerging Growth Equity Conference - GlobeNewsWire
23 days ago - Ocugen, Inc. (OCGN) Q3 2025 Earnings Call Transcript - Seeking Alpha
24 days ago - Ocugen Provides Business Update with Third Quarter 2025 Financial Results - GlobeNewsWire
5 weeks ago - Ocugen to Host Webcast on Wednesday, November 5 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2025 Financial Results - GlobeNewsWire
2 months ago - Ocugen: A Retinal Disease Juggernaut In The Making - Seeking Alpha
2 months ago - Why Ocugen Stock Zoomed 12% Higher Today - The Motley Fool
2 months ago - Ocugen Shares Are Trading Higher Monday: What's Going On? - Benzinga
2 months ago - Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea - GlobeNewsWire